Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 52009XC0501(01)

    Kopsavilkums par Kopienas lēmumiem attiecībā uz zāļu tirdzniecības atļaujām no 2009. gada 1. marta līdz 2009. gada 31. martam – (Publicēts atbilstīgi 13. pantam vai 38. pantam Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004 )

    OV C 101, 1.5.2009, p. 3–13 (BG, ES, CS, DA, DE, ET, EL, EN, FR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    1.5.2009   

    LV

    Eiropas Savienības Oficiālais Vēstnesis

    C 101/3

    Kopsavilkums par Kopienas lēmumiem attiecībā uz zāļu tirdzniecības atļaujām no 2009. gada 1. marta līdz 2009. gada 31. martam

    (Publicēts atbilstīgi 13. pantam vai 38. pantam Eiropas Parlamenta un Padomes Regulā (EK) Nr. 726/2004  (1) )

    2009/C 101/03

    —   Tirdzniecības atļaujas izsniegšana (13. pants Regulā (EK) No726/2004): Pieņemts

    Lēmuma datums

    Zāļu nosaukums

    SNN

    (Starptautiskais nepatentētais nosaukums)

    Tirdzniecības atļaujas turētājs

    Ieraksta numurs Kopienas reģistrā

    Farmaceitiskā forma

    ATĶ kods

    (Anatomiski terapeitiski ķīmiskais kods)

    Paziņojuma datums

    4.3.2009.

    CELVAPAN

    Pandēmiskās gripas vakcīna (H5N1 vesels virions, iegūts Vero šūnās, inaktivēts)

    Baxter AG

    Industriestraße 67

    A - 1221 Wien

    ÖSTERREICH

    EU/1/08/506/001

    Suspensija injekcijām

    J07BB01

    6.3.2009.

    6.3.2009.

    MEPACT

    mifamurtīds

    IDM Pharma S.A.

    47 rue de Chaillot

    75116 Paris

    FRANCE

    EU/1/08/502/001

    Pulveris infūziju suspensijas pagatavošanai

    L03AX15

    23.3.2009.

    19.3.2009.

    Fertavid

    follitropin beta

    SP Europe

    Rue de Stalle

    73 B-1180 Bruxelles

    BELGIQUE

    EU/1/09/510/001-019

    Šķīdums injekcijām

    G03G A06

    23.3.2009.

    30.3.2009.

    Synflorix

    Konjugēta pneimokoku polisaharīda vakcīna (adsorbēta)

    GlaxoSmithKline Biologicals S.A.

    rue de l'Institut 89

    1330 Rixensart

    BELGIQUE

    EU/1/09/508/001-009

    Suspensija injekcijām

    J07AL52

    31.3.2009.

    31.3.2009.

    Ribavirin Teva

    Ribavirīns

    Teva Pharma B.V.

    Computerweg 10

    3542 DR Utrecht

    NEDERLAND

    EU/1/09/509/001-004

    Cietā kapsula

    J05A B04

    2.4.2009.

    31.3.2009.

    IXIARO

    Japānas encefalīta vakcīna (inaktivēta, adsorbēta)

    Intercell AG

    Campus Vienna Biocenter 3

    A-1030 Wien

    ÖSTERREICH

    EU/1/08/501/001-002

    Suspensija injekcijai

    J07BA02

    2.4.2009.

    —   Tirdzniecības atļaujas izmaiņas (13. pants Regulā (EK) Nr. 726/2004): Pieņemts

    Lēmuma datums

    Zāļu nosaukums

    Tirdzniecības atļaujas turētājs

    Ieraksta numurs Kopienas reģistrā

    Paziņojuma datums

    2.3.2009.

    Fendrix

    GlaxoSmithKline Biologicals s.a.

    rue de l'Institut 89

    Rixensart, B-1330

    BELGIQUE

    EU/1/04/299/001-003

    4.3.2009.

    2.3.2009.

    Cymbalta

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/04/296/001-009

    4.3.2009.

    2.3.2009.

    Fareston

    Orion Corporation

    Orionintie 1

    FIN-02200 Espoo

    SUOMI

    EU/1/96/004/001-002

    4.3.2009.

    2.3.2009.

    Nexavar

    Bayer HealthCare AG

    D-51368 Leverkusen

    DEUTSCHLAND

    EU/1/06/342/001

    4.3.2009.

    2.3.2009.

    Irbesartan BMS

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road

    Uxbridge UB8 1DH

    UNITED KINGDOM

    EU/1/06/375/001-033

    4.3.2009.

    2.3.2009.

    Aptivus

    Boehringer Ingelheim International GmbH

    Binger Strasse 173- D - 55216

    Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/05/315/001

    4.3.2009.

    2.3.2009.

    Ganfort

    Allergan Pharmaceuticals Ireland

    Castlebar Road

    Westport, Co. Mayo

    IRELAND

    EU/1/06/340/001-002

    5.3.2009.

    4.3.2009.

    KOGENATE Bayer

    Bayer HealthCare AG

    51368 Leverkusen

    DEUTSCHLAND

    EU/1/00/143/001-011

    6.3.2009.

    4.3.2009.

    Helixate NexGen

    Bayer HealthCare AG

    51368 Leverkusen

    DEUTSCHLAND

    EU/1/00/144/001-004

    6.3.2009.

    4.3.2009.

    Gardasil

    Sanofi Pasteur MSD

    SNC, 8, rue Jonas Salk

    69007 Lyon

    FRANCE

    EU/1/06/357/001-021

    6.3.2009.

    4.3.2009.

    Cystadane

    Orphan Europe S.a.r.l.

    Immeuble Le Wilson,

    70 Avenue du Général de Gaulle

    92800 Puteaux

    FRANCE

    EU/1/06/379/001

    6.3.2009.

    4.3.2009.

    Photobarr

    Axcan Pharma International BV

    Engelenkampstraat 72

    6131 JJ Sittard

    NEDERLAND

    EU/1/04/272/001-002

    6.3.2009.

    6.3.2009.

    Silgard

    Merck Sharp & Dohme Ltd

    Hertford Road, Hoddesdon

    Hertfordshire EN11 9BU

    UNITED KINGDOM

    EU/1/06/358/001-021

    10.3.2009.

    6.3.2009.

    BYETTA

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/06/362/001-004

    10.3.2009.

    6.3.2009.

    IntronA

    Schering Plough Europe

    Rue de Stalle, 73

    1180 Bruxelles

    BELGIQUE

    EU/1/99/127/001-044

    10.3.2009.

    6.3.2009.

    Remicade

    Centocor B.V.

    Einsteinweg 101

    2333 CB Leiden

    NEDERLAND

    EU/1/99/116/001-005

    10.3.2009.

    6.3.2009.

    Protelos

    Les Laboratoires Servier

    22, rue Garnier

    92200 Neuilly-sur-Seine

    FRANCE

    EU/1/04/288/001-006

    10.3.2009.

    6.3.2009.

    ATryn

    LEO Pharma A/S

    Industriparken 55

    DK-2750 Ballerup

    DANMARK

    EU/1/06/355/001-003

    10.3.2009.

    6.3.2009.

    Irbesartan Hydrochlorothiazide Winthrop

    SANOFI PHARMA BRISTOL MYERS SQUIBB SNC

    174 avenue de France

    F- 75013 Paris

    FRANCE

    EU/1/06/377/001-028

    10.3.2009.

    9.3.2009.

    Optisulin

    Sanofi-Aventis Deutschland GmbH

    D-65926 Frankfurt am Main

    DEUTSCHLAND

    EU/1/00/133/001-032

    11.3.2009.

    9.3.2009.

    Osseor

    Les Laboratoires Servier

    22, rue Garnier

    92200 Neuilly-sur-Seine

    FRANCE

    EU/1/04/287/001-006

    11.3.2009.

    9.3.2009.

    Sustiva

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road

    Uxbridge UB8 1DH

    UNITED KINGDOM

    EU/1/99/110/001-009

    11.3.2009.

    10.3.2009.

    DULOXETINE BOEHRINGER INGELHEIM

    Boehringer Ingelheim International GmbH

    Binger Strasse 173 - D - 55216

    Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/08/471/001-012

    12.3.2009.

    17.3.2009.

    Pritor Plus

    Bayer HealthCare AG

    51368 Leverkusen

    DEUTSCHLAND

    EU/1/02/215/001-021

    19.3.2009.

    17.3.2009.

    Irbesartan Winthrop

    SANOFI PHARMA BRISTOL MYERS SQUIBB SNC

    174 avenue de France

    F- 75013 Paris

    FRANCE

    EU/1/06/376/001-033

    19.3.2009.

    17.3.2009.

    Pritor

    Bayer HealthCare AG

    51368 Leverkusen

    DEUTSCHLAND

    EU/1/98/089/001-022

    19.3.2009.

    17.3.2009.

    Hycamtin

    SmithKline Beecham plc

    980 Great West Road, Brentford

    Middlesex,TW8 9GS

    UNITED KINGDOM

    EU/1/96/027/001

    EU/1/96/027/003-007

    19.3.2009.

    17.3.2009.

    Onsenal

    Pfizer Limited

    Ramsgate Road, Sandwich

    Kent CT13 9NJ

    UNITED KINGDOM

    EU/1/03/259/001-006

    19.3.2009.

    18.3.2009.

    Irbesartan HCT BMS

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road

    Uxbridge UB8 1DH

    UNITED KINGDOM

    EU/1/06/369/001-028

    20.3.2009.

    18.3.2009.

    Atriance

    Glaxo Group Limited

    Berkeley Avenue, Greenford

    Middlesex UB6 0NN

    UNITED KINGDOM

    EU/1/07/403/001

    20.3.2009.

    18.3.2009.

    Kinzalkomb

    Bayer HealthCare AG

    51368 Leverkusen

    DEUTSCHLAND

    EU/1/02/214/001-015

    20.3.2009.

    18.3.2009.

    MicardisPlus

    Boehringer Ingelheim International GmbH

    Binger Strasse 173- D - 55216

    Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/02/213/001-023

    20.3.2009.

    18.3.2009.

    Kinzalmono

    Bayer HealthCare AG

    51368 Leverkusen

    DEUTSCHLAND

    EU/1/98/091/001-014

    20.3.2009.

    19.3.2009.

    Regranex

    Janssen-Cilag International NV

    Turnhoutseweg

    30 - 2340 Beerse –

    BELGIË

    EU/1/99/101/001

    23.3.2009.

    19.3.2009.

    Stalevo

    Orion Corporation

    Orionintie 1

    FIN-02200 Espoo

    SUOMI

    EU/1/03/260/001-023

    23.3.2009.

    19.3.2009

    Micardis

    Boehringer Ingelheim International GmbH

    Binger Strasse 173- D - 55216

    Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/98/090/001-020

    23.3.2009.

    19.3.2009.

    Vectibix

    Amgen Europe B.V.

    Minervum 7061

    NL-4817 ZK Breda

    NEDERLAND

    EU/1/07/423/001-003

    23.3.2009.

    23.3.2009.

    NovoSeven

    Novo Nordisk A/S

    Novo Allé

    DK-2880 Bagsvaerd

    DANMARK

    EU/1/96/006/001-003

    25.3.2009.

    23.3.2009.

    Irbesartan BMS

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road

    Uxbridge UB8 1DH

    UNITED KINGDOM

    EU/1/06/375/001-033

    25.3.2009.

    25.3.2009.

    Avastin

    Roche Registration Limited

    6 Falcon Way, Shire Park

    Welwyn Garden City, AL7 1TW

    UNITED KINGDOM

    EU/1/04/300/001-002

    27.3.2009.

    25.3.2009.

    Enbrel

    Wyeth Europa Limited

    Huntercombe Lane South, Taplow

    Maidenhead, Berkshire, SL6 0PH

    UNITED KINGDOM

    EU/1/99/126/001-018

    27.3.2009.

    25.3.2009.

    Telzir

    Glaxo Group Ltd.

    Greenford Road, Greenford

    Middlesex UB6 0NN

    UNITED KINGDOM

    EU/1/04/282/001-002

    27.3.2009.

    25.3.2009.

    Ariclaim

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/04/283/001-012

    27.3.2009.

    25.3.2009.

    Exjade

    Novartis Europharm Limited

    Wimblehurst Road, Horsham

    West Sussex RH12 5AB

    UNITED KINGDOM

    EU/1/06/356/001-009

    27.3.2009.

    25.3.2009.

    Arixtra

    Glaxo Group Ltd.

    Greenford Road, Greenford

    Middlesex UB6 0NN

    UNITED KINGDOM

    EU/1/02/206/001-035

    27.3.2009.

    25.3.2009.

    Xenical

    Roche Registration Limited

    6 Falcon Way, Shire Park

    Welwyn Garden City, AL7 1TW

    UNITED KINGDOM

    EU/1/98/071/001-006

    27.3.2009.

    25.3.2009.

    Cymbalta

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/04/296/001-009

    27.3.2009.

    25.3.2009.

    Advagraf

    Astellas Pharma Europe B.V.

    Elisabethhof 19

    NL-2353 EW Leiderdorp

    NEDERLAND

    EU/1/07/387/001-010

    27.3.2009.

    25.3.2009.

    Pradaxa

    Boehringer Ingelheim International GmbH

    Binger Strasse 173

    D-55216 Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/08/442/001-008

    27.3.2009.

    25.3.2009.

    Zyprexa

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/96/022/002

    EU/1/96/022/004

    EU/1/96/022/006

    EU/1/96/022/008-012

    EU/1/96/022/014

    EU/1/96/022/016-017

    EU/1/96/022/019-034

    27.3.2009.

    25.3.2009.

    ProQuad

    Sanofi Pasteur MSD

    SNC, 8, rue Jonas Salk

    69007 Lyon

    FRANCE

    EU/1/05/323/001-013

    27.3.2009.

    25.3.2009.

    Cetrotide

    Serono Europe Limited

    56, Marsh Wall

    London E14 9TP

    UNITED KINGDOM

    EU/1/99/100/001-003

    27.3.2009.

    25.3.2009.

    Tyverb

    Glaxo Group Limited

    Berkeley Avenue, Greenford

    Middlesex UB6 0NN

    UNITED KINGDOM

    EU/1/07/440/001-002

    27.3.2009.

    25.3.2009.

    Lysodren

    Laboratoire HRA Pharma

    15, rue Béranger

    75003 Paris

    FRANCE

    EU/1/04/273/001

    27.3.2009.

    25.3.2009.

    Zyprexa Velotab

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/99/125/001-016

    27.3.2009.

    25.3.2009.

    Yondelis

    Pharma Mar, S.A.

    Avda. de los Reyes 1

    Polígono Industrial La Mina

    28770 Colmenar Viejo (Madrid)

    ESPAÑA

    EU/1/07/417/001-002

    27.3.2009.

    25.3.2009.

    Extavia

    Novartis Europharm Limited

    Wimblehurst Road, Horsham

    West Sussex RH12 5AB

    UNITED KINGDOM

    EU/1/08/454/001-002

    EU/1/08/454/005

    27.3.2009.

    25.3.2009.

    Mabthera

    Roche Registration Limited

    6 Falcon Way, Shire Park

    Welwyn Garden City, AL7 1TW

    UNITED KINGDOM

    EU/1/98/067/001-002

    27.3.2009.

    25.3.2009.

    Beromun

    Boehringer Ingelheim International GmbH

    Binger Strasse 173- D - 55216

    Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/99/097/001

    27.3.2009.

    25.3.2009.

    Dukoral

    SBL Vaccin AB

    S-105 21 Stockholm

    SWEDEN

    EU/1/03/263/001-003

    30.3.2009.

    25.3.2009.

    NeuroBloc

    Eisai Limited

    3, Shortlands

    London W6 8EE

    UNITED KINGDOM

    EU/1/00/166/001-003

    30.3.2009.

    25.3.2009.

    Xeristar

    Boehringer Ingelheim International GmbH

    Binger Strasse 173- D - 55216

    Ingelheim am Rhein

    DEUTSCHLAND

    EU/1/04/297/001-008

    27.3.2009.

    27.3.2009.

    Aerinaze

    SP Europe

    Rue de Stalle, 73, 1180 Bruxelles, Belgique -

    Stallestraat, 73 - 1180 Brussel,

    BELGIË

    EU/1/07/399/001-006

    1.4.2009.

    27.3.2009.

    Liprolog

    Eli Lilly Nederland B.V.

    Grootslag 1-5

    3991 RA Houten

    NEDERLAND

    EU/1/01/195/001-015

    EU/1/01/195/022-025

    1.4.2009.

    27.3.2009.

    Karvezide

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road

    Uxbridge UB8 1DH

    UNITED KINGDOM

    EU/1/98/085/001-034

    1.4.2009.

    27.3.2009.

    Irbesartan HCT Winthrop

    SANOFI PHARMA BRISTOL MYERS SQUIBB SNC

    174 avenue de France

    F- 75013 Paris

    FRANCE

    EU/1/06/377/001-028

    1.4.2009.

    27.3.2009.

    Litak

    Lipomed GmbH

    Schönaugasse 11

    D-79713 Bad Säckingen

    DEUTSCHLAND

    EU/1/04/275/001-002

    1.4.2009.

    27.3.2009.

    Procoralan

    Les Laboratoires Servier

    22, rue Garnier

    92200 Neuilly-sur-Seine

    FRANCE

    EU/1/05/316/001-014

    1.4.2009.

    27.3.2009.

    Mimpara

    Amgen Europe B.V.

    Minervum 7061

    NL-4817 ZK Breda

    NEDERLAND

    EU/1/04/292/001-012

    1.4.2009.

    27.3.2009.

    TRIZIVIR

    Glaxo Group Ltd.

    Greenford Road, Greenford

    Middlesex UB6 0NN

    UNITED KINGDOM

    EU/1/00/156/002-003

    1.4.2009.

    27.3.2009.

    Dafiro

    Novartis Europharm Limited

    Wimblehurst Road, Horsham

    West Sussex RH12 5AB

    UNITED KINGDOM

    EU/1/06/371/001-036

    1.4.2009.

    27.3.2009.

    Copalia

    Novartis Europharm Limited

    Wimblehurst Road, Horsham

    West Sussex RH12 5AB

    UNITED KINGDOM

    EU/1/06/372/001-036

    1.4.2009.

    27.3.2009.

    Imprida

    Novartis Europharm Limited

    Wimblehurst Road, Horsham

    West Sussex RH12 5AB

    UNITED KINGDOM

    EU/1/06/373/001-036

    1.4.2009.

    27.3.2009.

    Exforge

    Novartis Europharm Limited

    Wimblehurst Road, Horsham

    West Sussex RH12 5AB

    UNITED KINGDOM

    EU/1/06/370/001-036

    1.4.2009.

    27.3.2009.

    Stalevo

    Orion Corporation

    Orionintie 1

    FIN-02200 Espoo

    SUOMI

    EU/1/03/260/024-033

    1.4.2009.

    30.3.2009.

    Cholestagel

    Genzyme Europe B.V.

    Gooimeer 10

    NL-1411 DD Naarden

    NEDERLAND

    EU/1/03/268/001-004

    1.4.2009.

    31.3.2009.

    Rapilysin

    Actavis Group PTC ehf.

    Reykjavikurvegi 76-78

    220 Hafnarfjordur

    ICELAND

    EU/1/96/018/001

    2.4.2009.

    31.3.2009.

    Velcade

    Janssen-Cilag International NV

    Turnhoutseweg 30

    B-2340 Beerse

    BELGIË

    EU/1/04/274/001-002

    2.4.2009.

    31.3.2009.

    Aprovel

    Sanofi Pharma Bristol-Myers Squibb SNC

    174 avenue de France -

    75013 Paris

    FRANCE

    EU/1/97/046/001-039

    2.4.2009.

    31.3.2009.

    Karvea

    Bristol-Myers Squibb Pharma EEIG

    Uxbridge Business Park, Sanderson Road

    Uxbridge UB8 1DH

    UNITED KINGDOM

    EU/1/97/049/001-039

    2.4.2009.

    31.3.2009.

    CoAprovel

    Sanofi Pharma Bristol-Myers Squibb SNC

    174 avenue de France -

    75013 Paris

    FRANCE

    EU/1/98/086/001-034

    2.4.2009.

    —   Tirdzniecības atļaujas anulēšana (13. pants Regulā (EK) Nr. 726/2004)

    Lēmuma datums

    Zāļu nosaukums

    Tirdzniecības atļaujas turētājs

    Ieraksta numurs Kopienas reģistrā

    Paziņojuma datums

    17.3.2009.

    Dynepo

    Shire Pharmaceutical Contracts Ltd

    Hampshire International Business Park, Chineham, Basingstoke

    Hampshire RG24 8EP

    UNITED KINGDOM

    EU/1/02/211/001-005

    EU/1/02/211/010-012

    19.3.2009.

    —   Tirdzniecības atļaujas izsniegšana (38. pants Regulā (EK) Nr. 726/2004 (2)): Pieņemts

    Lēmuma datums

    Zāļu nosaukums

    SNN

    (Starptautiskais nepatentētais nosaukums)

    Tirdzniecības atļaujas turētājs

    Ieraksta numurs Kopienas reģistrā

    Farmaceitiskā forma

    ATĶ kods (Anatomiski terapeitiski ķīmiskais kods)

    Paziņojuma datums

    17.3.2009.

    BTVPUR Alsap 8

    Zilās mēles vīrusa serotipa 8 antigēns

    MERIAL

    29 avenue Tony Garnier

    69007 LYON

    FRANCE

    EU/2/09/094/001-005

    Suspensija injekcijai

    Q104AA02

    Q102AA08

    19.3.2009.

    —   Tirdzniecības atļaujas izmaiņas (38. pants Regulā (EK) Nr. 726/2004): Pieņemts

    Lēmuma datums

    Zāļu nosaukums

    Tirdzniecības atļaujas turētājs

    Ieraksta numurs Kopienas reģistrā

    Paziņojuma datums

    6.3.2009.

    Econor

    Novartis Animal Health Austria GmbH

    Biochemiestrasse 10

    6250 Kundl

    ÖSTERREICH

    EU/2/98/010/004-006

    EU/2/98/010/017-018

    EU/2/98/010/021-024

    10.3.2009.

    12.3.2009.

    Novem

    Boehringer Ingelheim Vetmedica GmbH

    55216 Ingelheim am Rhein

    DEUTSCHLAND

    EU/2/04/042/003-004

    16.3.2009.

    18.3.2009.

    Aivlosin

    ECO Animal Health Ltd

    78 Coombe Road New Malden

    Surrey KT3 4QS

    UNITED KINGDOM

    EU/2/04/044/001-008

    20.3.2009.

    23.3.2009.

    Equilis Prequenza Te

    Intervet International B.V.

    Wim de Körverstraat 35

    5831 AN Boxmeer

    NEDERLAND

    EU/2/05/057/001-004

    25.3.2009.

    23.3.2009.

    Equilis Prequenza

    Intervet International B.V.

    Wim de Körverstraat 35

    5831 AN Boxmeer

    NEDERLAND

    EU/2/05/056/001-004

    25.3.2009.

    25.3.2009.

    Quadrisol

    Intervet International B.V.

    Wim de Körverstraat 35

    5831 AN Boxmeer

    NEDERLAND

    EU/2/97/005/002-004

    EU/2/97/005/006-009

    27.3.2009.

    Ja vēlaties apskatīt publisko novērtējuma ziņojumu par attiecīgajām zālēm un ar tām saistītos lēmumus, lūdzam sazināties ar

    The European Medicines Agency

    7, Westferry Circus

    Canary Wharf

    London E14 4HB

    UNITED KINGDOM

    (1)  OV L 136, 30.4.2004., 1. lpp.

    (2)  OV L 136, 30.4.2004., 1. lpp.

    Top